TI
CDNA icon

Trexquant Investment’s CareDx CDNA Stock Holding History

Trexquant Investment’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
+45,908
New +$999K 0.01% 1369
2025
Q3 		– Sell
-281,349
Closed -$5.5M – 1619
2025
Q2 		$5.5M Sell
281,349
-28,394
-9% -$505K 0.06% 494
2025
Q1 		$5.5M Sell
309,743
-24,133
-7% -$520K 0.06% 464
2024
Q4 		$7.15M Buy
333,876
+125,363
+60% +$3.05M 0.08% 389
2024
Q3 		$6.51M Buy
+208,513
New +$5.19M 0.08% 370
2024
Q2 		– Sell
-103,138
Closed -$1.09M – 1545
2024
Q1 		$1.09M Buy
103,138
+45,118
+78% +$451K 0.02% 887
2023
Q4 		$696K Sell
58,020
-20,559
-26% -$168K 0.02% 954
2023
Q3 		$550K Sell
78,579
-118,331
-60% -$1.09M 0.01% 981
2023
Q2 		$1.67M Sell
196,910
-57,711
-23% -$481K 0.04% 556
2023
Q1 		$2.33M Buy
254,621
+106,387
+72% +$1.36M 0.06% 401
2022
Q4 		$1.69M Buy
148,234
+95,655
+182% +$1.42M 0.05% 470
2022
Q3 		$895K Buy
52,579
+15,247
+41% +$327K 0.03% 569
2022
Q2 		$802K Buy
+37,332
New +$1.04M 0.04% 613
2021
Q4 		– Sell
-5,480
Closed -$347K – 1330
2021
Q3 		$347K Buy
5,480
+2,314
+73% +$176K 0.03% 680
2021
Q2 		$290K Sell
3,166
-4,382
-58% -$348K 0.02% 730
2021
Q1 		$514K Buy
+7,548
New +$586K 0.05% 495
2020
Q4 		– Sell
-30,957
Closed -$1.18M – 1062
2020
Q3 		$1.18M Buy
30,957
+3,335
+12% +$113K 0.08% 357
2020
Q2 		$979K Buy
27,622
+14,183
+106% +$404K 0.07% 406
2020
Q1 		$293K Buy
13,439
+224
+2% +$5.02K 0.02% 855
2019
Q4 		$285K Sell
13,215
-31,118
-70% -$714K 0.02% 762
2019
Q3 		$1M Buy
44,333
+35,098
+380% +$972K 0.09% 285
2019
Q2 		$332K Buy
+9,235
New +$296K 0.03% 571
2018
Q2 		– Sell
-71,231
Closed -$568K – 928
2018
Q1 		$568K Buy
71,231
+54,862
+335% +$338K 0.04% 590
2017
Q4 		$120K Buy
+16,369
New +$102K 0.01% 996

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's CDNA Position: Q2 2026 in Review

Trexquant Investment opened a new position in CareDx (CDNA) in Q2 2026: 45,908 shares worth $1.31M. The stake represents 0.01% of the portfolio and ranks #1369 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in CDNA as recently as Q2 2025.

Trexquant Investment first reported a position in CDNA in Q4 2017 and has held it in 24 quarters since. The position peaked at $7.15M in Q4 2024. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Trexquant Investment held 45,908 shares of CareDx worth $1.31M as of Q2 2026.
  • CareDx was a new Trexquant Investment position in Q2 2026.
  • CareDx made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1369 holding.
  • Trexquant Investment first reported a position in CareDx in Q4 2017 and has held it in 24 quarters since.
  • Trexquant Investment's CareDx position peaked at $7.15M in Q4 2024.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.